Hospitality-rich areas of San Francisco’s struggling downtown could get a boost with the issuance of 20 more liquor licenses, ...
Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...
Fifty-nine people died of accidental drug overdoses in San Francisco in January. While that is still too many, health ...
17h
An open-air drug market has started to take over a San Francisco park at night — sparking concerns among neighbors. “It’s ...
The 59 deaths San Francisco recorded in January marked a 17% decrease from the same month in 2024 (71). January 2025 marked ...
CZI has signed a 225,000-square-foot lease in Redwood City's Elco Yards district, developed by Boston-based IQHQ.
The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...
AI companies are one of the subsets of the tech industry still taking space in San Francisco, raising hopes among CRE pros in ...
A European real estate titan now plans to keep — and not unload through property sales — a big chunk of its portfolio of U.S.
Dr. Lee will oversee the clinical development of Lycia’s lead programs, LCA-0061 for IgE-mediated diseases and LCA-0321 for ...
In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Jim Cramer, the host of Mad Money, on Tuesday, took a close look at President Donald ...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting off on a very different note. According to iSpot.TV’s analysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback